+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Modulation of lipoprotein lipase activity in the rat by the beta 2-adrenergic agonist clenbuterol



Modulation of lipoprotein lipase activity in the rat by the beta 2-adrenergic agonist clenbuterol



Canadian Journal of Physiology and Pharmacology 70(12): 1555-1562



This study evaluated the effects of beta 2-adrenoceptor stimulation on some determinants of triglyceride metabolism. Male Sprague-Dawley rats were injected twice daily with clenbuterol (30 micrograms.kg-1) for 7 days, or with an equivalent volume of vehicle. Serum triglycerides, hepatic triglyceride secretion rate, and lipoprotein lipase activity in white and brown adipose tissues as well as in red vastus lateralis muscle and heart were evaluated in the fasting state and following a fat-free, high-sucrose meal, 3 h after the last agonist injection. In rats killed in the fasting and postprandial states, clenbuterol reduced the mass of white adipose tissue (-25 and -12%, respectively; p < 0.02), whereas it increased the mass of vastus lateralis muscle (+11 and +7%; p < 0.002) and heart (+13 and %; p < 0.0001). In vehicle-injected animals, the fasting state was associated with lower lipoprotein lipase activity in white and brown adipose tissues, and higher enzyme activity in vastus lateralis and heart, compared with the postprandial state. Postprandially, treatment with clenbuterol reduced lipoprotein lipase activity in white adipose (-24%), whereas it increased enzyme activity in brown adipose (+107%) as well as in vastus lateralis (+35%). In fasted animals, no significant variation of enzyme activity in these tissues was observed following clenbuterol treatment, whereas in the heart, a decrease of lipoprotein lipase activity was observed (-22%). Clenbuterol lowered serum triglycerides significantly (-23%), but not their rate of secretion, whereas the agonist decreased the insulin to glucagon ratio only in the postprandial state.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040719323

Download citation: RISBibTeXText

PMID: 1363787


Related references

Modulation of lipoprotein lipase activity in the rat by the 2 -adrenergic agonist clenbuterol. Canadian Journal of Physiology and Pharmacology 70(12): 1555-1562, 1992

Effect of beta-2-adrenergic agonist clenbuterol on plasma lipoprotein fractions, fatty acid content and muscle fiber types in chickens. Medycyna Weterynaryjna 50(9): 457-460, 1994

Selective regulation of beta-2 adrenergic receptors by the chronic administration of the lipophilic beta adrenergic receptor agonist clenbuterol: an autoradiographic study. Journal of Pharmacology and Experimental Therapeutics 242(2): 707-712, 1987

Selective regulation of beta 2 adrenergic receptors by chronic administration of the lipophilic beta adrenergic receptor agonist clenbuterol an autoradiographic study. Journal of Pharmacology & Experimental Therapeutics 242(2): 707-712, 1987

Abnormal insulin and beta-adrenergic modulation of lipoprotein lipase during refeeding after prolonged fasting in the Zucker rat. Diabetologia 43(7): 866-874, 2000

Modulation in vivo of the beta 1 adrenergic and beta 2 adrenergic receptor messenger rna level in lean and obese zucker fa fa rat brown adipose tissue by the thermogenic beta adrenergic agonist ro 16 8714. Experientia 46(ABSTR): A32, 1990

Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number. Journal of Clinical Investigation 65(4): 836-840, 1980

Clenbuterol a beta 2 adrenoceptor agonist induces desensitization of beta 2 adrenergic vasodilation. Journal of Clinical Pharmacology 28(10): 923, 1988

Beta-adrenergic blockade and lipoprotein lipase activity in rat tissues after acute exercise. American Journal of Physiology 261(4 Pt 2): R891-R897, 1991

Subchronic infusion of clenbuterol, a beta-adrenergic agonist, decreases the cerebellar beta receptor. Neuroscience Letters 36(1): 93-97, 1983

Transforming growth factor beta s are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta(2) adrenergic agonist. British Journal of Pharmacology 147(4): 412-421, 2006

Beta adrenergic blockade does not prevent the acute exercise induced decrease in lipoprotein lipase lpl activity in the rat. FASEB Journal 4(4): A927, 1990

Accumulation of the beta(2)-adrenergic agonist clenbuterol in mouse dark hair. Archives of Toxicology 83(11): 979-983, 2009

Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies. Rinsho Shinkeigaku 41(10): 698-700, 2001

Effects of the beta -adrenergic agonist clenbuterol on the growth of skeletal muscle in the rat. Archives of Animal Nutrition 45(4): 333-344, 1994